HCD, now part of Prime, is a health economics and outcomes research consultancy team specializing in decision-ready evidence to inform and challenge healthcare policy, enabling better patient outcomes in an increasingly complex and resource-constrained environment.
Prime HCD is a core part of Prime's expanding Evidence & Access capability, working alongside Prime Access and the US based Prime Aventine to deliver integrated global support.
Our multidisciplinary team spans market access, HEOR, real-world evidence, and value strategy, supporting clients across both US and global markets.
With unified leadership across these groups, we provide an integrated value proposition —helping clients navigate increasingly complex global environments and prepare their products for sustainable and successful market entry.
In summary we provide:
- Full HEOR & RWE capabilities
- Deep US‑focused market access and payer engagement expertise
- Value dossiers, payer evidence packages, and PIE materials
- Reimbursement and access strategy backed by real‑world and economic evidence
- Integrated value communication across scientific, medical, and HEOR domains
For further information about Prime please visit our website.